T cell homing to the kidney contributes to salt retention and blood pressure regulation
T 细胞归巢至肾脏有助于盐潴留和血压调节
基本信息
- 批准号:10394209
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdoptive TransferAffectAnimalsAntigensAttentionBlood PressureCD8 AntigensCD8-Positive T-LymphocytesCardiovascular DiseasesCell Adhesion MoleculesCell CommunicationCellsDOCADefectDevelopmentDistalDistal convoluted renal tubule structureEquilibriumEventExcess Dietary SaltExtracellular FluidFutureGeneticGoalsHealthHomeostasisHomingHypertensionImmune System DiseasesImmunologicsImmunotherapyImpairmentIn VitroInfiltrationInterferon Type IIInterruptionKidneyKnock-outKnockout MiceMediatingMethodsModelingMolecularMusMyocardial InfarctionNephronsOrgan failurePathogenesisPathway interactionsPerfusionPlayPotassium ChannelProcessProductionPublic HealthRegulationRenal HypertensionRenal tubule structureReportingResearchRoleSLC12A3 geneSignal TransductionSignaling MoleculeSodiumSodium ChlorideStimulusStrokeSurfaceT-Cell ActivationT-LymphocyteTestingTimeTubular formationUp-RegulationWaterWithdrawaladaptive immunitybaseblood pressure elevationblood pressure reductionblood pressure regulationcell typecytokinedesignepithelial Na+ channelexperimental studyhypertensiveimmunological synapsein vivokidney cellknock-downnephrogenesisnew therapeutic targetnoveloverexpressionpressurepreventprogrammed cell death ligand 1public health relevancesalt sensitive hypertensionsymportertherapeutic targettherapeutically effectivethiazide
项目摘要
PROJECT SUMMARY / ABSTRACT
The kidneys are important regulators of blood pressure. They regulate circulatory volume by controlling
sodium and water balance, thus maintaining extracellular fluid volume homeostasis. It is well established that
the pathogenesis of salt-sensitive hypertension is caused by impaired sodium handling in the kidneys, but the
critical factors leading to renal sodium retention remain unidentified. An important role for T cells in
hypertension has been proposed in the past decade. However, no related feasible treatment options have
been proposed, because the mechanisms underlying this role for T cells have not been elucidated. We
recently identified a novel role for kidney-infiltrated CD8+ T cells (CD8Ts) in enhancing salt retention; renal
infiltrated CD8Ts interact with distal convoluted tubule cells (DCTs), stimulating the sodium-chloride co-
transporter (NCC) in the DCTs, resulting in elevation of blood pressure. These findings led us to hypothesize
that the interaction between CD8Ts and renal tubular cells mediates T cell-homing to the kidney, which may
represent a kidney defect that contributes to the pathogenesis of salt sensitive hypertension. In the proposed
study, we will investigate the critical molecular determinants in the kidney, by which CD8Ts interact with renal
tubular cells and determine how this kidney-homing mechanism of CD8Ts contributes to excessive salt
retention, leading to high blood pressure. Specifically, Aim 1 will test our hypothesis that cytokines produced
from activated CD8Ts prime DCTs to express co-signaling molecule, which initiates the interaction between
DCTs and CD8Ts; Aim 2 will identify the adhesion molecules that mediate a putative immunological synapse
between these two cell types. Aim 3 will determine the critical role of potassium channel Kir4.1 in CD8T-
induced upregulation of NCC and possibly other sodium transporters in the distal nephron, leading to
excessive salt retention and consequent elevation of blood pressure. Our preliminary studies have identified
key molecules for each Aim. As proof of principle experiments, immunological neutralization or genetic
deletion of these molecules in the kidneys of mice prevented stimuli-induced upregulation of NCC in the
kidney and consequently lowered blood pressure. Complementary in vivo and in vitro studies are designed in
this proposal to accomplish our aims. We will use kidney-specific knockout or knockdown methods in animals
to determine the precise roles of key molecules in this study. Accomplishing our aims will elucidate the
important molecular mechanisms regarding T cell homing to the kidney, thus impairing salt and volume
homeostasis, and affecting blood pressure. We propose that salt-sensitive hypertension is caused, at least in
part, by immune disorders in the kidney. Moreover, the key molecules identified in this study may represent
novel targets for future immunotherapy against this prevalent health problem.
项目摘要/摘要
肾脏是血压的重要调节器。它们通过控制血流量来调节循环量
钠和水平衡,从而维持细胞外液容量的动态平衡。众所周知,
盐敏感型高血压的发病机制是由肾脏对钠的处理受损引起的,但
导致肾钠滞留的关键因素仍未确定。T细胞在人类免疫系统中的重要作用
高血压是在过去的十年中被提出的。然而,没有相关的可行的治疗方案
被提出,因为T细胞这种作用的潜在机制还没有被阐明。我们
最近发现了肾脏浸润性CD8+T细胞(CD8+T细胞)在增强盐滞留方面的新作用;肾脏
浸润性CD8T细胞与远端曲小管细胞(DCT)相互作用,刺激
DCT中的转运体(NCC),导致血压升高。这些发现让我们提出了假设
CD8T和肾小管细胞之间的相互作用介导T细胞归巢到肾脏,这可能是
代表肾脏缺陷,导致盐敏感型高血压的发病机制。在建议的
在这项研究中,我们将研究肾脏中CD8T与肾脏相互作用的关键分子决定因素
并确定CD8T的这种肾归巢机制是如何导致过量盐的
滞留,导致高血压。具体地说,目标1将测试我们的假设,即细胞因子产生
活化的CD8T激活DCT表达共信号分子,从而启动DCT与CD8T之间的相互作用
DCT和CD8T;AIM 2将识别介导假定的免疫突触的黏附分子
在这两种细胞类型之间。AIM 3将确定钾通道Kir4.1在CD8T中的关键作用
诱导NCC和可能的其他钠转运体在远端肾单位上调,导致
盐分滞留过多,导致血压升高。我们的初步研究已经确定
每个目标的关键分子。作为原则性实验的证明,免疫中和或基因
小鼠肾脏中这些分子的缺失可阻止刺激诱导的NCC在小鼠肾脏中的上调
肾脏,从而降低血压。体内和体外互补研究设计于
这项建议是为了实现我们的目标。我们将在动物身上使用肾脏特异性基因敲除或基因敲除方法
以确定关键分子在这项研究中的确切作用。实现我们的目标将阐明
T细胞归巢到肾脏的重要分子机制,从而损害盐分和体积
动态平衡,并影响血压。我们认为盐敏感型高血压至少是由
部分原因是肾脏的免疫功能紊乱。此外,这项研究中确定的关键分子可能代表
针对这一普遍的健康问题,未来免疫治疗的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shengyu Mu其他文献
Shengyu Mu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shengyu Mu', 18)}}的其他基金
T cell homing to the kidney contributes to salt retention and blood pressure regulation
T 细胞归巢至肾脏有助于盐潴留和血压调节
- 批准号:
9888420 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
T cell homing to the kidney contributes to salt retention and blood pressure regulation
T 细胞归巢至肾脏有助于盐潴留和血压调节
- 批准号:
10608091 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 38万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 38万 - 项目类别:














{{item.name}}会员




